P/E của cổ phiếu ENOV là bao nhiêu?

ENOVIS CORP (ENOV) hiện giao dịch ở mức P/E -200.52 lần.

ROE của cổ phiếu ENOV là bao nhiêu?

ENOVIS CORP có tỷ suất lợi nhuận trên vốn chủ sở hữu (ROE) -77.00%.

Tỷ suất cổ tức của ENOV là bao nhiêu?

ENOVIS CORP có tỷ suất cổ tức 0.00%.

Điểm chất lượng (Quality Score) của ENOV là bao nhiêu?

AI của chúng tôi đánh giá chất lượng tài chính tổng thể của ENOV ở mức 46/100, dựa trên khả năng sinh lời, tăng trưởng, nợ và độ ổn định lợi nhuận.

Bây giờ có nên mua cổ phiếu ENOV không?

Điểm AI Timing của ENOV là 91/100, thể hiện mức độ hấp dẫn tương đối của giá hiện tại theo tín hiệu kỹ thuật và momentum — nên cân nhắc cùng điểm chất lượng và kế hoạch đầu tư của bạn.

Cổ phiếu ENOV thuộc ngành nào?

ENOVIS CORP được xếp vào ngành Healthcare >> Medical Devices trên sàn NYSE

Cổ phiếu ENOV (NYSE) | ENOVIS CORP

Stock Check Daily update data at 8:30 AM
(Price: 2026-07-31 | FS: 2026-03-31)

ENOV AI Analysis Summary

Our AI summary for ENOV: ENOVIS CORP (NYSE), Healthcare >> Medical Devices sector. The stock currently trades at a P/E of -200.52, ROE of -77.00%, a dividend yield of 0.00%. Its financial Quality Score stands at 46/100 — fundamentals below the market average. The AI Timing Score is 91/100 — multiple technical signals currently support price momentum. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

ENOV

ENOVIS CORP

US:NYSE STOCK Healthcare >> Medical Devices News 99

USD 29.15

-0.15 (-0.51%) Day Change

Watchlist Portfolio Compare Chart

-200.52

P/E

0.91

D/E

-77.0%

ROE

-29.7%

ROA

0.00%

Div Yield

-0.24

PEG

ENOVIS CORP
TYPE: STOCK
MARKET: NYSE

Compare Watchlist Myport

USD 29.15 Price -0.15 (-0.51%) Day Change	NEWS SCORE: 99

ENOV Chất lượng tổng thể của cố phiếu Không tốt ( Chất lượng = 46) nhưng Thời điểm mua ...(Sign In to See)...

Loading chart...

46 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: Tỷ lệ ROE tương đối thấp
Tỷ lệ ROA tương đối thấp
Lịch sử ROE tương đối thấp
Tăng trưởng ROE là âm trong năm ngoái.
Tăng trưởng ROA dưới mức tiêu chí của chúng tôi trong năm vừa qua
Biên lợi nhuận ròng tương đối thấp.
Lịch sử Biên lợi nhuận ròng tương đối thấp.

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

Chi tiết hơn, sẽ thấy rằng các yếu tố chất lượng Không tốt , Sức khỏe tài chính Không tốt , và khả năng kiếm lợi nhuận Khá , ...

Yếu tố Chất lượng

48%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	99
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	29.15
PBV / Sector	1.14 / -101.57 GREAT
Earning Per Share	-19.66

PE / Sector	N/A / 31.23
PEG or PE/Growth / Sector	-0.24 / 0.40
Average 1M Daily Value	24.89 M GREAT
Average 1W Daily Value	23.62 M GREAT

Yếu tố Kỹ thuật

71%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Sức khỏe tài chính

45%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Khả năng kiếm lợi nhuận

62%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	-49.91 / 20.50
NPM Average (%) / Sector	-28.91 / -15.37
NPM Change Average (%) / Sector	517.18 / 7.34 GREAT
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-29.68 / 39.11
ROA Average (%) / Sector	-15.82 / 5.58
ROA Change Average (%) / Sector	620.37 / 104.50 GREAT
ROE (%) / Sector	-77.00 / -166.42
ROE Average (%) / Sector	-38.02 / -16.93
ROE Change Average (%) / Sector	876.80 / -500.08 GREAT
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Lợi tức cho nhà đầu tư

Dividend (%) / Sector	N/A / 0.43
Dividend Average (%) / Sector	N/A / 1.85
Dividend Change Average (%) / Sector	N/A / 3.44

Chi tiết đăng ký

Analyze Date	2026-08-01 07:59:47
Symbol	ENOV
Name	ENOVIS CORP
Sector	Healthcare >> Medical Devices
Market	NYSE
Listed Shares	57.56 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	1,686.58 / 20,104.97

Tin tức, Dự báo ước tính

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 2711 Centerville Road, Wilmington, DE, United States, 19808

Phone: 302 252 9160

Website: https://www.enovis.com

Employees: 7,802

Sector: Healthcare >> Medical Devices

Description: Enovis Corporation, a medical technology company, focuses on developing clinically differentiated solutions in the United States and internationally. It operates through two segments: Prevention and Recovery, and Reconstructive segments. The Prevention and Recovery segment offers rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, electrical stimulators for pain management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions. The Reconstructive segment develops, manufactures, markets, and distributes surgical solutions that restore mobility and improve patient outcomes, which includes a range of differentiated implants, instrumentation, and enabling technologies used in elective and non-elective joint replacement, limb reconstruction, and foot and ankle procedures; and products for the hip, knee, shoulder, elbow, extremity reconstruction and fixation, foot, ankle, and finger, as well as surgical productivity tools. It also manufactures and distributes a range of products which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company distributes its products through independent distributors, direct salespeople, and patients. The company was formerly known as Colfax Corporation. Enovis Corporation was founded in 1995 and is headquartered in Wilmington, Delaware.